ArticleTranslational lung cancer research2022
Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer.
Editorial OfficePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.